IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes / A.T. Taher, J.B. Porter, A. Kattamis, V. Viprakasit, M.D. Cappellini. - In: DRUG DESIGN, DEVELOPMENT AND THERAPY. - ISSN 1177-8881. - 10(2016), pp. 4073-4078. [10.2147/DDDT.S117080]

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes

M.D. Cappellini
Ultimo
2016
benzoates; drug therapy, combination; humans; iron; iron chelating agents; pyridones; syndrome; thalassemia; triazoles; chelation therapy; deferoxamine; pharmacology; 3003; drug discovery3003 pharmaceutical science
Settore MED/09 - Medicina Interna
2016
Article (author)
01 - Articolo su periodico
File in questo prodotto:
File Dimensione Formato  
Cappellini_DrugDesignDevelopment_EfficacySafetyIron_2016.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 272.56 kB
Formato Adobe PDF
Visualizza/Apri
272.56 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/514893
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 12
social impact